APP and neuroblastoma: The experimental data in Figure 2 recapitulates our previous report that the APP 5’UTR competent transfectants of SH-SY5Y neuroblastoma cells showed anti-APP and anti-amyloid efficacy in response to 100 μM phenserine [20].